Skip to main content

Table 2 Pathways of the differentially expressed genes discovered by the DSLD2 method

From: A novel estimator of between-study variance in random-effects models

PathwayID

Pathway name

C

O

E

R

P-value

FDR

hsa05212

Pancreatic cancer

66

7

1.22

5.72

0.0002

0.060

hsa04010

MAPK signaling pathway

255

13

4.72

2.75

0.0008

0.062

hsa05200

Pathways in cancer

397

17

7.35

2.31

0.0009

0.062

hsa04012

ErbB signaling pathway

88

7

1.63

4.29

0.0011

0.062

hsa05131

Shigellosis

65

6

1.20

4.97

0.0012

0.062

hsa04962

Vasopressin-regulated water reabsorption

44

5

0.81

6.13

0.0012

0.062

hsa05120

Epithelial cell signaling in Helicobacterpylori infection

68

6

1.26

4.76

0.0015

0.066

hsa04392

Hippo signaling pathway

29

4

0.53

7.44

0.0018

0.066

hsa01522

Endocrine resistance

98

7

1.81

3.85

0.0021

0.066

hsa04520

Adherens junction

74

6

1.37

4.37

0.0023

0.066

  1. Note: C represents the number of reference genes in the category, O represents the number of genes in the category and also in the gene set, E represents expected number in the category, and R represents the ratio of enrichment